Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check3 days agoChange DetectedAn updated last update timestamp and minor formatting changes are visible; core study details, eligibility criteria, locations, and outcomes remain unchanged.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%

- Check31 days agoChange DetectedAdd: Revision: v3.1.0 to indicate a new version. Remove: several MedlinePlus topics and an earlier version tag (v3.0.2).SummaryDifference0.3%

- Check39 days agoChange DetectedThe page now includes newer date-related entries and a new “Plain Language Results Summary” link, while older date stamps from 2022 are removed. Overall, content meaning remains largely the same with updated time references.SummaryDifference0.7%

- Check46 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed. No substantive content changes were detected.SummaryDifference0.1%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.